GreensKeeper Value Fund Posts Q2 Recovery as ICON Surges 57%

A Quieter Quarter After Q1 Turbulence

GreensKeeper Value Fund released its Q2 2026 portfolio update this weekend, revealing a notably calmer period for the value shop after a turbulent start to the year. The Canadian firm, which manages a concentrated portfolio of quality businesses at discount prices, reported no major changes to holdings during the quarter.

Context matters here. GreensKeeper posted a negative 8.1% return in Q1, caught in the broader market selloff triggered by escalating Middle East tensions. That defensive posture the fund carried into 2026, with cash and equivalents sitting at 14.7% of the portfolio at year end, provided limited cushion against the geopolitical shocks. Q2 appears to have offered some relief, though the fund has not disclosed aggregate return figures in this update.

ICON plc: The 57% Surprise

The standout performer was ICON plc (ICLR), the Dublin-based contract research organization that surged 57% during the quarter. For longtime GreensKeeper holders, this shouldn't come as a complete surprise. The fund highlighted ICON in its Q1 letter as one of its key positions.

ICON's rally came despite an uneven fundamental picture. Q1 revenues rose just 0.9% year over year to $2.03 billion, and actually declined 1.9% in constant currency terms. The company's 2026 revenue guidance of $7.85 billion to $8.15 billion sits below the $8.25 billion generated in 2025. Part of that expected decline reflects the Symphony Health divestiture.

So what drove the surge? Commercial momentum and AI optimism. ICON posted net business wins of approximately $2.9 billion, achieving a 1.42 book to bill ratio and building its backlog to a record $22.7 billion. In late June, the company announced a Microsoft partnership to deploy AI tools including 365 Copilot and Azure across its operations, powering its Orbis agentic AI platform. The stock jumped more than 12% on that news alone.

Intercontinental Exchange: The 21.7% Drag

On the other side of the ledger, Intercontinental Exchange (ICE) declined 21.7% during Q2, making it the fund's largest detractor. The NYSE owner has struggled throughout 2026, with shares down roughly 16% year to date and 24% over the trailing twelve months through late June.

The weakness stands out against peers. CME Group rose 2.6% over the past year, while CBOE surged 54.3% and Nasdaq gained 11.3%. The S&P 500 added 33% during the same stretch. ICE's underperformance has caught the attention of institutional investors. Bank of Nova Scotia reduced its ICE position by 55.1% in Q1 according to recent 13F filings, and insider selling totaling $2.0 million over the past three months hasn't helped sentiment.

The fundamental story isn't broken. ICE continues to benefit from its Fixed Income and Data Services segment, with performance driven by CDS clearing and elevated macro volatility. Management expects recurring revenue growth in the mid single digit range for 2026. The company also made a $600 million strategic investment in Polymarket, the prediction market platform, signaling its interest in emerging data asset classes.

The Patience Trade

GreensKeeper's decision to make no major portfolio changes during Q2 reflects its long stated philosophy. The firm has consistently emphasized long term ownership and a willingness to endure short term volatility in exchange for compounding returns. In its Q4 2025 letter, management noted: "We remain committed to long-term ownership."

This patience has paid off historically. Alphabet, GreensKeeper's top performer in 2025, gained 64.8% that year and finished 120% above its April lows after a volatile stretch. American Express, the second largest contributor in 2025, returned 24.7%. The fund's largest holding, Berkshire Hathaway, has underperformed recently, trailing the S&P 500 by 40% over the past year in what the firm called "one of the worst periods of relative performance in its history." Yet GreensKeeper views Berkshire as fundamentally undervalued and noted that management resumed share buybacks.

The concentration in ICE, despite its drawdown, suggests conviction. Analysts surveyed by Zacks carry an average price target of $200.63, implying more than 31% upside from recent levels. GuruFocus estimates a fair value of $166.30, putting the current price at a 19% discount.

What the Portfolio Tells Us About Regime

GreensKeeper's holdings read like a late cycle quality playbook. The portfolio skews toward businesses with durable competitive positions, strong cash generation, and manageable capital intensity. Alphabet's dominance in search and AI infrastructure, Berkshire's $370 billion cash pile, Visa's network effects, and ICON's scale in clinical research all fit the template.

The fund's 14.7% cash position entering 2026 suggested wariness about valuations or macro conditions. That dry powder likely helped limit damage in Q1. Whether the fund deployed any of that cash during the selloff isn't clear from this update, though the "no major changes" language implies the core portfolio remained stable.

For value investors watching the interest rate regime, GreensKeeper's positioning offers a data point. The fund isn't reaching for cyclical leverage or betting on a rapid policy pivot. It's owning businesses that can compound through whatever rate environment emerges. That posture proved painful in 2025, when narrow leadership in mega cap tech dominated returns, but it aligns with a view that breadth will eventually matter again.

What to Watch in the Coming Weeks

The key question for GreensKeeper holders is whether Q2's ICON windfall represents sustainable momentum or a one quarter anomaly. ICON carries a P/E ratio near 63, pricing in significant growth and margin recovery. If the AI partnership with Microsoft fails to materially improve clinical trial economics, the valuation could compress as quickly as it expanded.

ICE's trajectory bears monitoring as well. The stock has shown signs of stabilization in recent weeks, bouncing almost 12% off its June lows according to recent technical analysis. Credit spreads and exchange volumes will tell us whether the franchise is simply out of favor or facing structural headwinds.

Broader market conditions will shape both positions. If the current environment of elevated macro volatility persists, exchange operators like ICE should eventually benefit. If AI enthusiasm continues driving healthcare services names, ICON has further to run. GreensKeeper appears content to let the businesses do the work while holding a concentrated book of compounders. The next meaningful update will likely come with Q3 results, when we'll see whether this quarter's divergence was noise or signal.